FindTrial
Sign In

Clinical Cohort Study of Takayasu's Arteritis

Clinical Cohort Study of Takayasu‘s Arteritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108234
Enrollment
Unknown
Registered
2025-08-27
Start date
2025-08-27
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takayasu's Arteritis

Interventions

Observation Group:None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Satisfy the 2022 ACR/EULAR classification criteria for TAK; >= 18 years old

Exclusion criteria

Exclusion criteria: Co-existing other autoimmune diseases; Malignant tumors

Design outcomes

Primary

MeasureTime frame
Kerr Score;—

Countries

China

Contacts

Public ContactRui Liu; Hui Wei

Peking University Third Hospital

weihui2012@bjmu.edu.cn+86 182 1004 8577

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026